Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
Authors
Keywords
Breast Cancer, Estrogen Receptor, Trastuzumab, Metastatic Breast Cancer, Everolimus
Journal
BREAST CANCER RESEARCH
Volume 16, Issue 2, Pages -
Publisher
Springer Nature
Online
2014-03-21
DOI
10.1186/bcr3630
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer
- (2013) Gaetano Aurilio et al. ACTA ONCOLOGICA
- Attitudes of patients with metastatic breast cancer toward research biopsies
- (2013) D. S. Seah et al. ANNALS OF ONCOLOGY
- Cancer heterogeneity: implications for targeted therapeutics
- (2013) R Fisher et al. BRITISH JOURNAL OF CANCER
- Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics
- (2013) W. Onstenk et al. CANCER TREATMENT REVIEWS
- Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the North Central Cancer Treatment Group N9831 Trial
- (2013) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- The economic burden of metastatic breast cancer: a U.S. managed care perspective
- (2012) Alberto J. Montero et al. BREAST CANCER RESEARCH AND TREATMENT
- Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers
- (2012) Stéphane Vignot et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
- (2012) R. J. Leary et al. Science Translational Medicine
- Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
- (2011) C. A. Gomez-Roca et al. ANNALS OF ONCOLOGY
- Should liver metastases of breast cancer be biopsied to improve treatment choice?
- (2011) G. Curigliano et al. ANNALS OF ONCOLOGY
- Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
- (2011) E. Brogi et al. ANNALS OF ONCOLOGY
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- (2011) Eitan Amir et al. CANCER TREATMENT REVIEWS
- Discordant Human Epidermal Growth Factor Receptor 2 and Hormone Receptor Status in Primary and Metastatic Breast Cancer and Response to Trastuzumab
- (2011) H. J. Chang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclin E amplification/overexpression is a mechanism of trastuzumab resistance in HER2+breast cancer patients
- (2011) Maurizio Scaltriti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss
- (2011) Giuseppe Bogina et al. VIRCHOWS ARCHIV
- Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer
- (2010) Pushpalatha K.A. Idirisinghe et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- HER2 status in a population-derived breast cancer cohort: discordances during tumor progression
- (2010) Ulla Wilking et al. BREAST CANCER RESEARCH AND TREATMENT
- Stability of estrogen receptor status in breast carcinoma
- (2010) Yun Gong et al. CANCER
- Quality Improvement Guidelines for Percutaneous Needle Biopsy
- (2010) Sanjay Gupta et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Estrogen and HER-2 Receptor Discordance Between Primary Breast Cancer and Metastasis
- (2010) L. Pusztai et al. ONCOLOGIST
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- (2009) S. J. Aitken et al. ANNALS OF ONCOLOGY
- Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer
- (2009) C. Liedtke et al. ANNALS OF ONCOLOGY
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
- (2009) F. Andre et al. CLINICAL CANCER RESEARCH
- Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
- (2009) E. A. Mittendorf et al. CLINICAL CANCER RESEARCH
- Breast cancer seeding associated with core needle biopsies: A systematic review
- (2009) Fabienne Liebens et al. MATURITAS
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- Overcoming Drug Resistance in Patients with Metastatic Breast Cancer
- (2009) Serena T Wong et al. PHARMACOTHERAPY
- HER-2/neu expression in primary and metastatic breast cancer
- (2008) Elyse E. Lower et al. BREAST CANCER RESEARCH AND TREATMENT
- Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
- (2008) J. M. Wu et al. CLINICAL CANCER RESEARCH
- Her2 cross talk and therapeutic resistance in breast cancer
- (2008) Laura et al. Frontiers in Bioscience-Landmark
- Comparison of HER-2 and Hormone Receptor Expression in Primary Breast Cancers and Asynchronous Paired Metastases: Impact on Patient Management
- (2008) V. Guarneri et al. ONCOLOGIST
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started